Dosulepin (Prothiaden) Dosing Recommendations
Based on available evidence, dosulepin should be initiated at 75 mg daily as a single bedtime dose in adults, with titration up to 150-225 mg/day as needed; however, patients over 65 years should receive reduced doses (maximum 75-100 mg/day), and the drug should be used with extreme caution or avoided entirely in those with cardiac disease, hepatic impairment, or renal insufficiency due to its narrow therapeutic index and high toxicity risk.
Standard Adult Dosing
The typical dosing regimen for dosulepin follows this pattern 1, 2:
- Starting dose: 75 mg once daily at bedtime
- Maintenance range: 75-150 mg/day
- Maximum dose: 225 mg/day (though 75% of patients respond to 125-150 mg/day) 3
- Administration: Single daily dose preferred over divided dosing, given at bedtime to minimize daytime sedation and improve insomnia symptoms 1, 2
The once-daily regimen is equally effective as divided dosing and offers better tolerability, particularly for sleep disturbances common in depression 1.
Elderly Patients (Over 65 Years)
Critical dose reduction is mandatory in older adults. While specific guidelines for dosulepin in the elderly are not explicitly detailed in the provided evidence, general principles for tricyclic antidepressants (TCAs) apply 4:
- Start low: Begin at 25-50 mg daily (lower than standard adult dose)
- Go slow: Increase by 25 mg every 3-7 days as tolerated
- Maximum: Generally should not exceed 75-100 mg/day in elderly patients
- Rationale: Decreased renal clearance with aging, increased sensitivity to anticholinergic and cardiovascular effects
Cardiac Disease
Dosulepin should be avoided or used with extreme caution in patients with cardiac disease. This is a critical safety consideration:
- Dosulepin, like other TCAs, can cause cardiac conduction abnormalities
- The drug is particularly dangerous in overdose, with high cardiotoxicity 5
- If absolutely necessary, use the lowest effective dose with careful cardiac monitoring (ECG baseline and follow-up)
- Consider alternative antidepressants with better cardiac safety profiles
Hepatic Impairment
Reduce dose significantly in hepatic impairment:
- Dosulepin undergoes extensive hepatic metabolism
- Start at 25-50 mg daily
- Titrate slowly with close monitoring for adverse effects
- Maximum dose should be substantially lower than standard dosing (consider 75-100 mg/day maximum)
- Monitor liver function tests regularly 6
The general principle for drugs metabolized hepatically is that moderate hepatic impairment requires dose reduction and careful monitoring 7, 8.
Renal Insufficiency
Dose reduction is necessary in renal impairment:
- While dosulepin is primarily hepatically metabolized, active metabolites may accumulate with renal dysfunction
- Start at 25-50 mg daily
- Increase cautiously with monitoring for toxicity
- Adjust dosing frequency if needed (consider every-other-day dosing in severe impairment)
- Monitor for increased anticholinergic and sedative effects 8
Critical Safety Considerations
Important caveats for all patients:
Toxicity risk: Dosulepin has been specifically targeted for reduced use due to high toxicity in overdose 5. The All Wales Medicines Strategy Group introduced monitoring specifically because of safety concerns.
Concomitant medications: Exercise caution with:
- Benzodiazepines (commonly co-prescribed but increases sedation risk)
- Other anticholinergic drugs
- Drugs affecting cardiac conduction
Monitoring requirements:
- Baseline ECG in patients >40 years or with cardiac risk factors
- Regular assessment for anticholinergic effects (dry mouth, constipation, urinary retention)
- Blood pressure monitoring (orthostatic hypotension risk)
Duration: Most patients (75%) can discontinue therapy by 9 months, though some require long-term treatment beyond 2 years 3
Practical Algorithm for Dose Selection
Step 1: Assess patient factors
- Age >65? → Reduce starting dose to 25-50 mg
- Cardiac disease? → Consider alternative antidepressant
- Hepatic impairment? → Start 25-50 mg, slow titration
- Renal impairment? → Start 25-50 mg, monitor closely
Step 2: Initiate therapy
- Standard adult: 75 mg at bedtime
- High-risk patient: 25-50 mg at bedtime
Step 3: Titrate based on response
- Increase by 25-50 mg every 1-2 weeks
- Target: Lowest effective dose (usually 75-150 mg/day)
- Maximum: 225 mg/day (standard adult), 75-100 mg/day (elderly/impaired)
Step 4: Monitor and adjust
- Assess efficacy at 4-6 weeks
- Monitor for adverse effects throughout
- Consider discontinuation if no response by 8-12 weeks